pediatrics

Children who have received radiotherapy for a brain tumor can develop cognitive problems later in life. In their studies on mice[1], researchers at Karolinska Institutet have now shown that the drug lithium can help to reverse the damage caused long after it has occurred. Nowadays, four out of five children with a brain tumor survive… Read more

An experimental molecular therapy in has been used in preclinical laboratory tests to effectively treat several types of deadly pediatric brain cancer. The researchers now propose advancing the treatment to clinical testing in children. The small molecule 6-thio-2’deoxyguanosine (6-thio-dG) was tested in brain cancer stem cells derived from tumor cells donated by patients. Researchers also… Read more

Larotrectinib, a first-of-its-kind drug targeting a fused gene found in many types of cancer was effective in 93 percent of pediatric patients tested, researchers at UT Southwestern’s Simmons Cancer Center has announced. Most cancer drugs are targeted to specific organs or locations in the body. Larotrectinib is the first cancer drug to receive FDA breakthrough… Read more

A new, 3-D method that could lead to new diagnostic tools that will precisely measure the third-trimester growth and folding patterns of a baby’s brain has been tested in research from a team at Washington University in St. Louis. The findings could help to sound an early alarm on developmental disorders in premature infants that… Read more

Babies given one egg a day for six months had improved growth compared with controls, as well as a reduced risk of stunted growth, research involving young children in Ecuador found. Stunted growth is when a child fails to meet the expected height or weight for their age. It can lead to long-term health problems… Read more